Stocks and Investing Stocks and Investing
Thu, February 17, 2022
[ 12:00 AM ] - United States, WOPRAI
Eric Martinuzzi Downgraded (BCOV) to Hold and Decreased Target to $9 on, Feb 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Matt Miksic Maintained (ALC) at Buy with Increased Target to $96 on, Feb 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Cecilia Furlong Maintained (ALC) at Hold with Decreased Target to $92 on, Feb 17th, 2022
Wed, February 16, 2022
[ 12:00 AM ] - United States, WOPRAI
John Newman Maintained (AGIO) at Strong Buy with Decreased Target to $44 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Roanna Ruiz Maintained (ALGS) at Buy with Decreased Target to $250 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Frank Louthan Maintained (AKAM) at Buy with Decreased Target to $118 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Fatima Boolani Maintained (AKAM) at Strong Buy with Decreased Target to $130 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Shebly Seyrafi Maintained (AKAM) at Buy with Decreased Target to $130 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Sterling Auty Maintained (AKAM) at Sell with Decreased Target to $115 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
James Fish Maintained (AKAM) at Hold with Decreased Target to $121 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian Peterson Maintained (ZI) at Buy with Decreased Target to $70 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Siti Panigrahi Maintained (ZI) at Strong Buy with Increased Target to $65 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Emily Chieng Maintained (AA) at Strong Buy with Increased Target to $88 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Ryskin Maintained (ZTS) at Strong Buy with Decreased Target to $254 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Justin Patterson Maintained (ABNB) at Buy with Increased Target to $210 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Thomas Champion Maintained (ABNB) at Hold with Increased Target to $194 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Bernie McTernan Maintained (ABNB) at Strong Buy with Increased Target to $220 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
James Lee Maintained (ABNB) at Hold with Increased Target to $205 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian Nowak Maintained (ABNB) at Hold with Increased Target to $175 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Stephen Ju Maintained (ABNB) at Hold with Increased Target to $185 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Deepak Mathivanan Maintained (ABNB) at Hold with Increased Target to $170 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Colin Sebastian Maintained (ABNB) at Buy with Increased Target to $210 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Tom White Maintained (ABNB) at Strong Buy with Increased Target to $235 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Naved Khan Maintained (ABNB) at Hold with Increased Target to $190 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Simeon Gutman Maintained (AAP) at Hold with Increased Target to $240 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Steven Zaccone Maintained (AAP) at Strong Buy with Increased Target to $294 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Steven Shemesh Maintained (AAP) at Hold with Increased Target to $247 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Roanna Ruiz Maintained (AMRN) at Buy with Decreased Target to $10 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Cyprys Maintained (ARES) at Hold with Increased Target to $93 on, Feb 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Mark Massaro Maintained (ADPT) at Strong Buy with Decreased Target to $30 on, Feb 16th, 2022

Mark Massaro Maintained (ADPT) at Strong Buy with Decreased Target to $30 on, Feb 16th, 2022


Published on 2024-10-27 19:42:46 - WOPRAI, Mark Massaro
  Print publication without navigation


Mark Massaro of BTIG, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Strong Buy with Decreased Target from $35 to $30 on, Feb 16th, 2022.

Mark has made no other calls on ADPT in the last 4 months.



There is 1 other peer that has a rating on ADPT. Out of the 1 peers that are also analyzing ADPT, all agrees with Mark's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Tejas Savant of "Morgan Stanley" Maintained at Hold with Decreased Target to $27 on, Tuesday, February 15th, 2022

Contributing Sources